Treatment

Investigation of a harmless prokaryotic virus for intravenous targeting delivery of therapeutic nucleic acids to DIPG

Mutational dynamics and their effect on chemoresistance and metastasis in a genetically engineered mouse model of relapsed neuroblastoma

The role of interclonal communication and the tumour microenvironment in driving paediatric GBM and DIPG migration and invasion

Children’s Brain Tumour Drug Delivery Consortium

Targeting c-MYB in acute leukaemia through drug repositioning

Convection-enhanced delivery of N3-propargyl, a novel analogue of temozolomide